|
Prevalence of established cardiovascular disease according to the presence of cardiac and/or renal damage. |
||||
| No ECG-LVH and no renal damage (28.6%) (Group A) |
ECG-LVH only (5.4%) (Group B) |
Renal damage only (48.4%) (Group C) |
ECG-LVH and renal damage (17.6%) (Group D) |
|
|
|
||||
| Cardiovascular disease (any), % |
37.7% |
58.9%A |
51.4%A |
70.6%A, C |
| Angina, % |
12.4% |
19.7%A |
14.7% |
22.0%A, C |
| Myocardial infarction, % |
13.1% |
25.4% |
17.5% |
28.2%A, C |
| Heart failure, % |
10.3% |
23.8%A |
20.6%A |
33.8%A |
| Peripheral vascular disease, % |
6.1% |
10.8% |
14.9%A |
28.0%A, B, C |
| Stroke, % |
11.9% |
13.8% |
18.2%A |
23.7%A |
| Atrial fibrillation, % |
7.8% |
18.0%A |
15.3%A |
22.5%A, C |
|
ECG-LVH: electrocardiographic left ventricular hypertrophy. Superscripts (A, B, C, D) mean p < 0.05 compared to the indicated group. | ||||
Cea-Calvo et al. Cardiovascular Diabetology 2006 5:23 doi:10.1186/1475-2840-5-23 |
||||